- ArQule (NASDAQ:ARQL) initiated with Buy rating and $13 (63% upside) price target at H.C. Wainwright.
- More news on: ArQule, Inc., Esperion Therapeutics, Inc., Aurora Cannabis Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 05:30:00 ET To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell of its former self. Instead of acquiring large cannabis compani...
The marijuana industry has been significantly hindered by Section 280E of the IRS Code , which prevents businesses dealing with substances listed in Schedules 1 and 2 of the Controlled Substances Act (CSA) from deducting regular business expenses. Although Section 280E affects federal deductio...